JP Morgan Chase
IDYA icon

JP Morgan Chase’s IDEAYA Biosciences IDYA Stock Holding History

JP Morgan Chase’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.93M Sell
267,494
-24,612
-8% -$753K ﹤0.01% 2804
2026
Q1 		$9.19M Sell
292,106
-7,782
-3% -$261K ﹤0.01% 2768
2025
Q4 		$10.4M Buy
299,888
+125,623
+72% +$4.01M ﹤0.01% 2648
2025
Q3 		$4.74M Sell
174,265
-272,155
-61% -$6.58M ﹤0.01% 3418
2025
Q2 		$9.38M Buy
446,420
+115,827
+35% +$2.22M ﹤0.01% 2616
2025
Q1 		$5.42M Buy
330,593
+55,900
+20% +$1.19M ﹤0.01% 3092
2024
Q4 		$7.06M Buy
274,693
+194,913
+244% +$5.52M ﹤0.01% 3032
2024
Q3 		$2.53M Buy
79,780
+12,029
+18% +$456K ﹤0.01% 3814
2024
Q2 		$2.38M Sell
67,751
-25,219
-27% -$999K ﹤0.01% 3632
2024
Q1 		$4.08M Sell
92,970
-23,528
-20% -$1.01M ﹤0.01% 3270
2023
Q4 		$4.14M Buy
116,498
+3,728
+3% +$111K ﹤0.01% 3257
2023
Q3 		$3.04M Buy
112,770
+2,209
+2% +$56K ﹤0.01% 3216
2023
Q2 		$2.6M Buy
110,561
+74,138
+204% +$1.52M ﹤0.01% 3343
2023
Q1 		$500K Buy
36,423
+8,434
+30% +$141K ﹤0.01% 4504
2022
Q4 		$509K Buy
27,989
+5,625
+25% +$94.6K ﹤0.01% 4505
2022
Q3 		$334K Buy
22,364
+1,309
+6% +$17K ﹤0.01% 4691
2022
Q2 		$291K Buy
21,055
+997
+5% +$11.1K ﹤0.01% 4879
2022
Q1 		$224K Buy
20,058
+3,870
+24% +$57K ﹤0.01% 5129
2021
Q4 		$383K Sell
16,188
-8,594
-35% -$200K ﹤0.01% 4999
2021
Q3 		$632K Buy
24,782
+4,945
+25% +$115K ﹤0.01% 4590
2021
Q2 		$416K Sell
19,837
-12,013
-38% -$247K ﹤0.01% 4812
2021
Q1 		$749K Sell
31,850
-44,840
-58% -$866K ﹤0.01% 4425
2020
Q4 		$1.07M Buy
76,690
+60,296
+368% +$817K ﹤0.01% 3916
2020
Q3 		$194K Buy
16,394
+12,349
+305% +$153K ﹤0.01% 4375
2020
Q2 		$57K Buy
+4,045
New +$31.9K ﹤0.01% 4794

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

JP Morgan Chase's IDYA Position: Q2 2026 in Review

JP Morgan Chase reduced its IDEAYA Biosciences (IDYA) stake by 8.4% in Q2 2026, selling an estimated $753K and leaving 267,494 shares worth $9.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2804.

JP Morgan Chase first reported a position in IDYA in Q2 2020 and has held it in 25 quarters since. The position peaked at $10.4M in Q4 2025. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • JP Morgan Chase held 267,494 shares of IDEAYA Biosciences worth $9.93M as of Q2 2026.
  • JP Morgan Chase sold 24,612 IDEAYA Biosciences shares in Q2 2026, an estimated $753K.
  • IDEAYA Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2804 holding.
  • JP Morgan Chase first reported a position in IDEAYA Biosciences in Q2 2020 and has held it in 25 quarters since.
  • JP Morgan Chase's IDEAYA Biosciences position peaked at $10.4M in Q4 2025.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.